Drugs used for neurologic and psychiatric conditions increase the risk for bullous pemphigoid: A case–control study - 21/06/19
Doi : 10.1016/j.jaad.2019.02.017
Outi Varpuluoma, MD, PhD a, b, Jari Jokelainen, MSc c, d, Anna-Kaisa Försti, MD, PhD a, b, Miia Turpeinen, MD, PhD e, f, Markku Timonen, MD, PhD d, Laura Huilaja, MD, PhD a, b, ⁎ 
, Kaisa Tasanen, MD, PhD a, b
, Kaisa Tasanen, MD, PhD a, b a PEDEGO Research Unit, University of Oulu, Oulu, Finland
c Unit of General Practice, University of Oulu, Oulu, Finland
d Center for Life Course Epidemiology and Systems Medicine, University of Oulu, Oulu, Finland
b Department of Dermatology and Medical Research Center Oulu, Oulu University Hospital, Finland
e Administration Center and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland
f Research Unit of Biomedicine, University of Oulu, Oulu, Finland
∗Correspondence to: Laura Huilaja, MD, PhD, Department of Dermatology, University of Oulu, Aapistie 5A, FIN-90029 Oulu, FinlandDepartment of DermatologyUniversity of OuluAapistie 5AOuluFIN-90029Finland
| Funding sources: Supported by a research grant from the Academy of Finland. |
|
| Conflicts of interest: None disclosed. |
|
| Reprints not available from the authors. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 81 - N° 1
P. 250-253 - juillet 2019 Retour au numéro
Article précédent
- Rhinophyma is associated with alcohol intake
- Julie Second, François Severac, Adrien Paix, Bernard Cribier
- Sun exposure risks in athletes who were recipients of solid organ and bone marrow transplants
- María V. de Gálvez, Jose M. Ruiz Sánchez, María Navarrete-de Gálvez, José Aguilera, Magdalena de Troya-Martín, Francisco Rivas-Ruiz, Enrique Herrera-Ceballos
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?